EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

CAR T cell persistence in cancer

Katherine P Mueller, Jeremy M Grenier, Evan W Weber

Trends in Cancer · 2025-10 · 11 (10) · 1005-1018

DOI: 10.1016/j.trecan.2025.08.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-10. Verfasst von Katherine P Mueller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Center for Chil…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Neoplasms, Receptors, Chimeric Antigen, T-Lymphocytes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute, Pediatric Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T cell (CAR T) therapies are 'living drugs' in which T cells are genetically engineered to recognize and kill cancer cells. A major barrier to progress for CAR T targeting liquid and solid tumors is the poor persistence of these cells in vivo, which limits therapeutic efficacy. In this review, we summarize the field's current understanding of CAR T persistence, including clinical observations, patient correlatives and multiomics approaches, and emerging cell engineering and manufacturing strategies. We also propose a conceptual framework for CAR T persistence to guide interpretation of clinical data and the design of more potent and efficacious CAR T therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveNeoplasmsReceptors, Chimeric AntigenT-LymphocytesReceptors, Antigen, T-CellHumansAnimalsCell Engineering

Stichwörter der Autor:innen

CAR TT cell exhaustioncancerimmunotherapypersistence

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philad…

Förderung

  • NCI NIH HHS
  • National Institutes of Health National Cancer Institute
  • Pediatric Cancer Foundation
  • Cancer Research Institute
  • V Foundation
  • Prostate Cancer Foundation
  • National Institutes of Health

Zitieren

APA

Mueller, K. P., Grenier, J. M., & Weber, E. W. (2025). CAR T cell persistence in cancer. Trends in Cancer, 11(10), 1005-1018. https://doi.org/10.1016/j.trecan.2025.08.014

Vancouver

Mueller KP, Grenier JM, Weber EW. CAR T cell persistence in cancer. Trends in Cancer. 2025;11(10):1005-1018. doi:10.1016/j.trecan.2025.08.014

BibTeX
@article{Mueller2025,
  author = {Mueller, Katherine P and Grenier, Jeremy M and Weber, Evan W},
  title = {CAR T cell persistence in cancer},
  journal = {Trends in Cancer},
  year = {2025},
  volume = {11},
  number = {10},
  pages = {1005--1018},
  doi = {10.1016/j.trecan.2025.08.014}
}
Kostenlos starten →